Of the HSP-inducing compounds available, geranylgeranylacetone (GGA) and GGA-derivatives have been tested for their potential to reverse AF-induced structural damage in HL-1 atrial cardiomyocytes [18,69]. This evidence concerns the gene HSP90B2P and atrial fibrillation.